287 related articles for article (PubMed ID: 25963298)
21. [Pathogenesis of chronic lymphocytic leukemia].
Fukuda T
Rinsho Ketsueki; 2015 Mar; 56(3):261-8. PubMed ID: 25876778
[TBL] [Abstract][Full Text] [Related]
22. NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.
Villamor N; Conde L; Martínez-Trillos A; Cazorla M; Navarro A; Beà S; López C; Colomer D; Pinyol M; Aymerich M; Rozman M; Abrisqueta P; Baumann T; Delgado J; Giné E; González-Díaz M; Hernández JM; Colado E; Payer AR; Rayon C; Navarro B; José Terol M; Bosch F; Quesada V; Puente XS; López-Otín C; Jares P; Pereira A; Campo E; López-Guillermo A
Leukemia; 2013 Apr; 27(5):1100-6. PubMed ID: 23295735
[TBL] [Abstract][Full Text] [Related]
23. Acquired initiating mutations in early hematopoietic cells of CLL patients.
Damm F; Mylonas E; Cosson A; Yoshida K; Della Valle V; Mouly E; Diop M; Scourzic L; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Kikushige Y; Davi F; Lambert J; Gautheret D; Merle-Béral H; Sutton L; Dessen P; Solary E; Akashi K; Vainchenker W; Mercher T; Droin N; Ogawa S; Nguyen-Khac F; Bernard OA
Cancer Discov; 2014 Sep; 4(9):1088-101. PubMed ID: 24920063
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease.
Vlad A; Deglesne PA; Letestu R; Saint-Georges S; Chevallier N; Baran-Marszak F; Varin-Blank N; Ajchenbaum-Cymbalista F; Ledoux D
Cancer Res; 2009 Aug; 69(16):6387-95. PubMed ID: 19654311
[TBL] [Abstract][Full Text] [Related]
25. Chronic lymphocytic leukaemia--the role of the microenvironment pathogenesis and therapy.
Ramsay AD; Rodriguez-Justo M
Br J Haematol; 2013 Jul; 162(1):15-24. PubMed ID: 23617880
[TBL] [Abstract][Full Text] [Related]
26. Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1, SF3B1, and TP53.
Zent CS; Burack WR
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):119-24. PubMed ID: 25696844
[TBL] [Abstract][Full Text] [Related]
27. Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitors.
Mato A; Jauhari S; Schuster SJ
Am J Hematol; 2015 Jul; 90(7):657-64. PubMed ID: 25808792
[TBL] [Abstract][Full Text] [Related]
28. Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia.
Leeksma AC; Taylor J; Wu B; Gardner JR; He J; Nahas M; Gonen M; Alemayehu WG; Te Raa D; Walther T; Hüllein J; Dietrich S; Claus R; de Boer F; de Heer K; Dubois J; Dampmann M; Dürig J; van Oers MHJ; Geisler CH; Eldering E; Levine RL; Miller V; Mughal T; Lamanna N; Frattini MG; Heaney ML; Zelenetz A; Zenz T; Abdel-Wahab O; Kater AP
Leukemia; 2019 Feb; 33(2):390-402. PubMed ID: 30038380
[TBL] [Abstract][Full Text] [Related]
29. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia.
Stevenson FK; Forconi F; Packham G
Semin Hematol; 2014 Jul; 51(3):158-67. PubMed ID: 25048780
[TBL] [Abstract][Full Text] [Related]
30. Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression.
Deglesne PA; Chevallier N; Letestu R; Baran-Marszak F; Beitar T; Salanoubat C; Sanhes L; Nataf J; Roger C; Varin-Blank N; Ajchenbaum-Cymbalista F
Cancer Res; 2006 Jul; 66(14):7158-66. PubMed ID: 16849562
[TBL] [Abstract][Full Text] [Related]
31. Targeting the tumor promoting effects of adenosine in chronic lymphocytic leukemia.
Cai Y; Feng L; Wang X
Crit Rev Oncol Hematol; 2018 Jun; 126():24-31. PubMed ID: 29759563
[TBL] [Abstract][Full Text] [Related]
32. The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome.
Brieghel C; da Cunha-Bang C; Yde CW; Schmidt AY; Kinalis S; Nadeu F; Andersen MA; Jacobsen LO; Andersen MK; Pedersen LB; Delgado J; Baumann T; Mattsson M; Mansouri L; Rosenquist R; Campo E; Nielsen FC; Niemann CU
Clin Cancer Res; 2020 Mar; 26(6):1507-1515. PubMed ID: 31919133
[TBL] [Abstract][Full Text] [Related]
33. [The genetic landscape of chronic lymphocytic leukemia].
Marosvári D; Alpár D; Király AP; Rajnai H; Reiniger L; Bödör C
Magy Onkol; 2016 Jun; 60(2):118-25. PubMed ID: 27275638
[TBL] [Abstract][Full Text] [Related]
34. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
[TBL] [Abstract][Full Text] [Related]
35. Using the biology of chronic lymphocytic leukemia to choose treatment.
Hillmen P
Hematology Am Soc Hematol Educ Program; 2011; 2011():104-9. PubMed ID: 22160020
[TBL] [Abstract][Full Text] [Related]
36. TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemia.
Malcikova J; Pavlova S; Kozubik KS; Pospisilova S
Hum Mutat; 2014 Jun; 35(6):663-71. PubMed ID: 24415659
[TBL] [Abstract][Full Text] [Related]
37. Antigens in chronic lymphocytic leukemia--implications for cell origin and leukemogenesis.
Rosén A; Murray F; Evaldsson C; Rosenquist R
Semin Cancer Biol; 2010 Dec; 20(6):400-9. PubMed ID: 20863893
[TBL] [Abstract][Full Text] [Related]
38. The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy.
Packham G; Krysov S; Allen A; Savelyeva N; Steele AJ; Forconi F; Stevenson FK
Haematologica; 2014 Jul; 99(7):1138-48. PubMed ID: 24986876
[TBL] [Abstract][Full Text] [Related]
39. Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia.
Hurtado AM; Chen-Liang TH; Przychodzen B; Hamedi C; Muñoz-Ballester J; Dienes B; García-Malo MD; Antón AI; de Arriba F; Teruel-Montoya R; Ortuño FJ; Vicente V; Maciejewski JP; Jerez A
Blood Cancer J; 2015 Aug; 5(8):e342. PubMed ID: 26314984
[TBL] [Abstract][Full Text] [Related]
40. [Molecular Prognostic Markers and Their Clinical Relevance in Chronic Lymphocytic Leukemia].
Navrkalová V; Kantorová B; Jarošová M; Pospíšilová Š
Klin Onkol; 2015; 28 Suppl 3():3S6-15. PubMed ID: 26489496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
